Starpharma Holdings Limited Stock price

Equities

SPL

AU000000SPL0

Pharmaceuticals

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
0.125 AUD -3.85% Intraday chart for Starpharma Holdings Limited 0.00% -26.47%
Sales 2022 5.16M 3.35M Sales 2023 4.21M 2.73M Capitalization 127M 82.69M
Net income 2022 -16M -10.4M Net income 2023 -15M -9.75M EV / Sales 2022 50.5 x
Net cash position 2022 41.73M 27.11M Net cash position 2023 26.91M 17.48M EV / Sales 2023 23.8 x
P/E ratio 2022
-18.5 x
P/E ratio 2023
-7.75 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 92.78%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.85%
Current month-7.41%
1 month-3.85%
3 months-30.56%
6 months-26.47%
Current year-26.47%
More quotes
1 week
0.12
Extreme 0.12
0.14
1 month
0.12
Extreme 0.12
0.14
Current year
0.12
Extreme 0.12
0.19
1 year
0.12
Extreme 0.12
0.53
3 years
0.12
Extreme 0.12
2.19
5 years
0.12
Extreme 0.12
2.52
10 years
0.12
Extreme 0.12
2.52
More quotes
Managers TitleAgeSince
Chief Executive Officer - Jan. 07
Director of Finance/CFO - 23-04-02
Corporate Officer/Principal - 13-08-11
Members of the board TitleAgeSince
Director/Board Member - 22-03-31
Chairman 79 13-12-03
Director/Board Member 53 20-02-29
More insiders
Date Price Change Volume
24-03-28 0.125 -3.85% 352 229
24-03-27 0.13 0.00% 59,110
24-03-26 0.13 0.00% 407,099
24-03-25 0.13 +4.00% 84,027
24-03-22 0.125 0.00% 125,174

Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT

More quotes
Starpharma Holdings Limited is an Australia-based global biopharmaceutical company engaged in the development of pharmaceutical and medical products based on polymers called dendrimers with programs for respiratory viruses, Dendrimer Enhanced Product (DEP) drug delivery and VivaGel. The Company's products include VIRALEZE, VivaGel condom and VivaGel BV. VIRALEZE product is applied to the nasal cavity where respiratory viruses that cause colds, flu, and more severe respiratory illness, attach and start to multiply. VIRALEZE also provides a moisturizing and protective barrier in the nose and contains SPL7013. VivaGel is an agent applied to a range of marketed women's health and sexual wellness products. VivaGel BV is a novel therapy for bacterial vaginosis (BV), the vaginal infection. VivaGelBV is available for sale under the brand names Betafem BV Gel (UK), Betadine BV (Europe), Betadine BV Gel (Asia) and Fleurstat BVgel (Australia & New Zealand) and licensed in over 160 countries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Starpharma Holdings Limited - Australian S.E.